Table 2 Soluble mesothelin levels pre- and post- therapeutic plasma exchange.

From: Evaluating therapeutic plasma exchange and protease inhibitors as mechanisms to reduce soluble mesothelin

Patient

Pre-TPE

Post-TPE

% change

1

21.11

15.4

− 27.05

2

26.77

14.61

− 45.42

3

9.47

5.12

− 45.93

4

72.31

22.68

− 68.64

5

6.47

4.8

− 25.81

6

20.33

12.29

− 39.55

7

10.01

6.08

− 39.26

8

7.33

5.75

− 21.56

9

25.78

21.06

− 18.31

10

2.17

0.66

− 69.59

11

17.58

9.84

− 44.03

12

15.26

9.24

− 39.45

13

62.56

42.57

− 31.95

14

101.43

6.73

− 93.36

15

22.7

12.8

− 43.61

  1. TPE, Therapeutic plasma exchange.
  2. Measured in ng/mL.
Back to article page